Isatuximab
| Isatuximab | |
|---|---|
| Term | Isatuximab |
| Short definition | Isatuximab (I-suh-TUK-sih-mab) A drug used with other drugs to treat adults with multiple myeloma. It is used in patients whose cancer has already been treated with at least two therapies, including lenalidomide and a proteasome inhibitor. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Isatuximab - (pronounced) (I-suh-TUK-sih-mab) A drug used with other drugs to treat adults with multiple myeloma. It is used in patients whose cancer has already been treated with at least two therapies, including lenalidomide and a proteasome inhibitor. It is also used in patients whose cancer has come back (come back) or has not improved after treatment with one to three other therapies. It is also being studied in the treatment of other types of cancer. Isatuximab attaches to a protein called CD38, which is found on some types of immune cells and cancer cells, including myeloma cells. Isatuximab can block CD38 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called Sarclisa
External links
- Medical encyclopedia article on Isatuximab
- Wikipedia's article - Isatuximab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski